These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38438600)

  • 1. Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitions.
    Khalili S; Safavi-Naini SAA; Zarand P; Masoumi S; Farsi Y; Hosseinpanah F; Azizi F
    Sci Rep; 2024 Mar; 14(1):5244. PubMed ID: 38438600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: A systematic review and meta-analysis.
    Iqbal J; Wu HX; Nawaz MA; Jiang HL; Xu SN; Huang BL; Li L; Cai JM; Zhou HD
    Obes Rev; 2024 Feb; 25(2):e13656. PubMed ID: 37904643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese.
    Wang Y; Sun B; Sheng LT; Pan XF; Zhou Y; Zhu J; Li X; Yang K; Guo K; Zhang X; He M; Yang H; Wu T; Pan A
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2017-2026. PubMed ID: 32826134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically healthy obesity, transition from metabolic healthy to unhealthy status, and carotid atherosclerosis.
    Huang Q; Liu Z; Wei M; Feng J; Huang Q; Liu Y; Liu Z; Li X; Yin L; Xia J
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3766. PubMed ID: 38351639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.
    Chen HY; Lu FH; Chang CJ; Wang RS; Yang YC; Chang YF; Wu JS
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):418-425. PubMed ID: 31744713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of chronic kidney disease in a metabolically healthy obese population.
    Jung CH; Lee MJ; Kang YM; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Kidney Int; 2015 Oct; 88(4):843-50. PubMed ID: 26108064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic health status and renal disorders: a cross-sectional study.
    Moeinzadeh F; Rouhani MH; Seirafian S; Vahdat S; Mortazavi M; Clark CCT; Shahdadian F
    Sci Rep; 2023 Nov; 13(1):20794. PubMed ID: 38012254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
    Zhao L; Zou Y; Wu Y; Cai L; Zhao Y; Wang Y; Xiao X; Yang Q; Yang J; Ren H; Tong N; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1103251. PubMed ID: 37234807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Different Obesity Phenotypes on Incidence of Chronic Kidney Disease in Tehranian Adults.
    Mottaghi A; Mirmiran P; Delshad H; Azizi F
    J Am Coll Nutr; 2016; 35(7):587-596. PubMed ID: 26650689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
    Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease.
    Nam KH; Yun HR; Joo YS; Kim J; Lee S; Lee C; Park KS; Park JT; Chang TI; Kang EW; Yoo TH; Kang SW; Han SH
    Diabetes Obes Metab; 2018 Dec; 20(12):2778-2791. PubMed ID: 29971899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study.
    Wang J; Niratharakumar K; Gokhale K; Tahrani AA; Taverner T; Thomas GN; Dasgupta I
    Am J Kidney Dis; 2022 Jan; 79(1):24-35.e1. PubMed ID: 34146618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.
    Jam SA; Moloudpour B; Najafi F; Darbandi M; Pasdar Y
    BMC Nephrol; 2022 Jul; 23(1):233. PubMed ID: 35778682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of childhood obesity phenotypes with early adulthood Carotid Intima-Media Thickness (CIMT): Tehran lipid and glucose study.
    Tasdighi E; Barzin M; Mahdavi M; Valizadeh M; Dehghan P; Moghaddam AM; Azizi F; Momenan AA; Hosseinpanah F
    Nutr Metab Cardiovasc Dis; 2022 Jan; 32(1):249-257. PubMed ID: 34802846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta-analysis.
    Kanbay M; Copur S; Siriopol D; Yildiz AB; Berkkan M; Tuttle KR; Zoccali C
    Eur J Clin Invest; 2023 Jan; 53(1):e13878. PubMed ID: 36120818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity, Metabolic Abnormality, and Progression of CKD.
    Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
    Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.